Combined choline and DHA supplementation: a randomized controlled trial.

Abstract

Choline and docosahexaenoic acid (DHA) are essential nutrients for preterm infant development. They are metabolically linked via phosphatidylcholine (PC), a constitutive plasma membrane lipid and the major transport form of DHA in plasma. Plasma choline and DHA-PC concentrations rapidly decline after preterm birth. To improve preterm infant nutrition, we evaluated combined compared to exclusive choline and DHA supplementation, and standard feeding. Randomized partially blinded single-center trial. Neonatal tertiary referral center in Tübingen, Germany. 24 inborn preterm infants < 32 week postmenstrual age. Standard nutrition (control) or, additionally, enteral choline (30mg/kg/day), DHA (60mg/kg/day), or both for 10days. Single enteral administration of 3.6mg/kg [methyl-D9-] choline chloride as a tracer at 7.5days. Primary outcome variable was plasma choline following 7 days of supplementation. Deuterated and unlabeled choline metabolites, DHA-PC, and other PC species were secondary outcome variables. Choline supplementation increased plasma choline to near-fetal concentrations [35.4 (32.8-41.7)µmol/L vs. 17.8 (16.1-22.4) µmol/L, p < 0.01] and decreased D9-choline enrichment of PC. Single DHA treatment decreased DHA in PC relative to total lipid [66 (60-68)% vs. 78 (74-80)%; p < 0.01], which was prevented by choline. DHA alone increased DHA-PC only by 35 (26-45)%, but combined treatment by 63 (49-74)% (p < 0.001). D9-choline enrichment showed preferential synthesis of PC containing linoleic acid. PC synthesis via phosphatidylethanolamine methylation resulted in preferential synthesis of DHA-containing D3-PC, which was increased by choline supplementation. 30mg/kg/day additional choline supplementation increases plasma choline to near-fetal concentrations, dilutes the D9-choline tracer via increased precursor concentrations and improves DHA homeostasis in preterm infants. clinicaltrials.gov. Identifier: NCT02509728.